Evidence map›Paper›PMID 32499788›Full record

ArticleFrontiers in immunology2020

Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD.

Punnam Chander Veerati, Niamh M Troy, Andrew T Reid, Ngan Fung Li, Kristy S Nichol, Parwinder Kaur, Steven Maltby, Peter A B Wark, Darryl A Knight, Anthony Bosco and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Frontiers in immunology · 2021
    Pooled it
  3. Trial
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. A translational view of airway epithelial dysfunction in COPD.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Unveiling the prevalence and impact of silent rhinovirus infection in chronic rhinosinusitis with nasal polyps.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Article
  18. Targeting respiratory virus-induced reactive oxygen species in airways diseases.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Punnam Chander VeeratiSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Niamh M TroySystems Immunology, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
Andrew T ReidSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Ngan Fung LiPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.
Kristy S NicholSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Parwinder KaurUWA School of Agriculture and Environment, Faculty of Science, The University of Western Australia, Perth, WA, Australia.
Steven MaltbyPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.
Peter A B WarkSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Darryl A KnightPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.
Anthony BoscoSystems Immunology, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
Chris L GraingeSchool of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Nathan W BartlettPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.
Hunter Medical Research Institute · AUUniversity of Newcastle Australia · AUJohn Hunter Hospital · AUThe University of Western Australia · AUProvidence Health Care Research Institute · CAThe Kids Research Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory viral infections, particularly those caused by rhinovirus, exacerbate chronic respiratory inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Airway epithelial cells are the primary site of rhinovirus replication and responsible of initiating the host immune response to infection. Numerous studies have reported that the anti-viral innate immune response (including type I and type III interferon) in asthma is less effective or deficient leading to the conclusion that epithelial innate immunity is a key determinant of disease severity during a rhinovirus induced exacerbation. However, deficient rhinovirus-induced epithelial interferon production in asthma has not always been observed. We hypothesized that disparate

Indexed as

Immunity, InnateAgedAsthmaCells, CulturedEpithelial CellsFemaleGene ExpressionHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRespiratory MucosaRhinovirusair-liquid interface (ALI) cultureasthmachronic obstructive pulmonary disease (COPD)innate immunityinterferon responserhinovirusRNA sequencing

Identifiers

PMID32499788
PMCPMC7243842
OpenAlexW3024846485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.